5 research outputs found

    Motivating Women to Travel in India:Embodying Safety as an Organizational Purpose

    No full text
    Safety concerns are a key factor that demotivate women from traveling. Tourism organizations are yet to develop approaches to address this comprehensively. Employing the case study design, this study describes how an Indian tourism organization adopted safe women travel as its purpose to reduce women’s safety risk perceptions and motivated them to travel. Nine qualitative interviews were conducted with key stakeholders including co-founders, employees, customers, and vendors. Data were analyzed using thematic analysis resulting in the identification of purpose as a pull factor. Themes of defining, communicating, embodying purpose, and its resulting influence were identified. Through this process, the organization was able to positively impact perceptions of safety, enhance women’s travel motivation, and develop long-term associations with all stakeholders. An actionable framework for implementing purpose was developed that can be used to align tourism organizations’ practices and activities

    Examining the effect of hunger on responses to pathogen cues and novel foods

    No full text
    Although multiple leading papers in the behavioral immune system literature have proposed that food deprivation affects responses to pathogen cues, evidence supporting this proposition is scarce. Here, we report results from what we believe to be the most comprehensive test of the effects of hunger on responses to pathogen cues to date. Participants (N = 40) recruited from a Dutch university attended two experimental sessions, each following a 15-hour fast. One of the two sessions was conducted immediately after eating a standardized meal, and the other was conducted before eating that same standardized meal. In each session, participants rated 40 different images (i.e., images depicting food-related pathogen cues, food-unrelated pathogen cues, violence, positive stimuli, and neutral stimuli) on valence and arousal while their heart rate and skin conductance responses were recorded. They also indicated their willingness to eat 16 novel foods. Results did not reveal an effect of nutritional state on explicit ratings of and physiological reactions to food-related or food-unrelated pathogen cues. However, participants reported a greater willingness to eat novel foods when hungry than when sated. These results raise doubt regarding proposals that short-term changes in nutritional state influence responses to pathogen cues, but they suggest that these same changes increase willingness to eat novel foods

    Disgust sensitivity relates to affective responses to – but not ability to detect – olfactory cues to pathogens

    No full text
    Hundreds of studies have assessed variation in the degree to which people experience disgust toward substances associated with pathogens, but little is known about the mechanistic sources of this variation. The current investigation uses olfactory perception and threshold methods to test whether it is apparent at the cue-detection level, at the cue-interpretation level, or both. It further tests whether relations between disgust sensitivity and olfactory perception are specific to odors associated with pathogens. Two studies (N's = 119 and 160) of individuals sampled from a Dutch university each revealed that pathogen disgust sensitivity relates to valence perceptions of odors found in pathogen sources, but not to valence perceptions of odors not associated with pathogens, nor to intensity perceptions of odors of either type. Study 2, which also assessed olfactory thresholds via a three-alternative forced-choice staircase method, did not reveal a relation between pathogen disgust sensitivity and the ability to detect an odor associated with pathogens, nor an odor not associated with pathogens. In total, results are consistent with the idea that pathogen disgust sensitivity relates to how olfactory pathogen cues are interpreted after detection, but not necessarily to the ability to detect such cues

    Ayurveda botanicals in COVID-19 management: An in silico multi-target approach.

    No full text
    The Coronavirus disease (COVID-19) caused by the virus SARS-CoV-2 has become a global pandemic in a very short time span. Currently, there is no specific treatment or vaccine to counter this highly contagious disease. There is an urgent need to find a specific cure for the disease and global efforts are directed at developing SARS-CoV-2 specific antivirals and immunomodulators. Ayurvedic Rasayana therapy has been traditionally used in India for its immunomodulatory and adaptogenic effects, and more recently has been included as therapeutic adjuvant for several maladies. Amongst several others, Withania somnifera (Ashwagandha), Tinospora cordifolia (Guduchi) and Asparagus racemosus (Shatavari) play an important role in Rasayana therapy. The objective of this study was to explore the immunomodulatory and anti SARS-CoV2 potential of phytoconstituents from Ashwagandha, Guduchi and Shatavari using network pharmacology and docking. The plant extracts were prepared as per ayurvedic procedures and a total of 31 phytoconstituents were identified using UHPLC-PDA and mass spectrometry studies. To assess the immunomodulatory potential of these phytoconstituents an in-silico network pharmacology model was constructed. The model predicts that the phytoconstituents possess the potential to modulate several targets in immune pathways potentially providing a protective role. To explore if these phytoconstituents also possess antiviral activity, docking was performed with the Spike protein, Main Protease and RNA dependent RNA polymerase of the virus. Interestingly, several phytoconstituents are predicted to possess good affinity for the three targets, suggesting their application for the termination of viral life cycle. Further, predictive tools indicate that there would not be adverse herb-drug pharmacokinetic-pharmacodynamic interactions with concomitantly administered drug therapy. We thus make a compelling case to evaluate the potential of these Rasayana botanicals as therapeutic adjuvants in the management of COVID-19 following rigorous experimental validation
    corecore